ArticleMolecular genetics & genomic medicine2026
Clinical and Genetic Characterization of Inherited NPRL3 Splice Variants in Two Patients With Epilepsy.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNPRL3-related epilepsy (NRE) is a GATORopathy characterized by focal seizures, with or without focal cortical dysplasia. Although NPRL3 variants have been associated with syndromes such as familial focal epilepsy with variable foci and sleep-related hypermotor epilepsy, the genotype-phenotype correlations in NRE remain poorly understood. This study aimed to investigate the clinical and genetic features of NRE in two Chinese families, together with a review of the genotype-phenotype spectrum.
methodsTwo pediatric Chinese patients with NRE were identified through whole-exome sequencing (WES). Clinical, neuroimaging, laboratory, and genetic data were analyzed. A review of reported NRE cases was conducted.
resultsInherited NPRL3 splice variants (NM_001077350.3: c.924 + 1G>A and c.925-1G>C) were identified in both probands using WES; both were inherited from their asymptomatic mothers. The patients presented with seizures starting at 1-2 years of age. Proband 1 experienced focal and focal to bilateral tonic-clonic seizures (FBTCS), while Proband 2 had focal seizures. Neuroimaging findings were normal. Patient 1 achieved seizure control with sodium valproate, oxcarbazepine, and lacosamide, while Patient 2 responded to oxcarbazepine and levetiracetam. A literature review of 41 articles identified 94 NPRL3 variants in 84 pedigrees and 23 cohort cases with epilepsy, revealing an estimated penetrance of 76% (162/214). Loss-of-function variants predominated (83%), while splice variants were relatively rare (13%). No clear genotype-phenotype correlations were observed, even in cases with identical NPRL3 variants.
conclusionThe findings of the study highlight the genetic and clinical heterogeneity of NRE, which is characterized by incomplete penetrance and phenotypic variability. This underscores the importance of tailored antiepileptic management and the consideration of NPRL3 variants as causes of familial and sporadic epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.